Evidence map›Paper›PMID 28329354›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies.

Chikara Ogimi, Alpana A Waghmare, Jane M Kuypers, Hu Xie, Cecilia C Yeung, Wendy M Leisenring, Sachiko Seo, Su-Mi Choi, Keith R Jerome, Janet A Englund and 1 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Non-COVID-19 respiratory viral infection.Breathe (Sheffield, England) · 2022
    Review
  11. Article
  12. Clinical outcomes in cancer patients with COVID-19.Cancer reports (Hoboken, N.J.) · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. SARS-CoV-2 infections in children and young people.Clinical immunology (Orlando, Fla.) · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Chikara OgimiVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
Alpana A WaghmareVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
Jane M KuypersVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
Hu XieClinical Research Division and.
Cecilia C YeungClinical Research Division and.
Wendy M LeisenringClinical Research Division and.
Sachiko SeoVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
Su-Mi ChoiDepartment of Internal Medicine, College of Medicine, Catholic University of Korea, Seoul; and.
Keith R JeromeVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
Janet A EnglundDepartment of Pediatrics, University of Washington.
Michael BoeckhVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center.
Fred Hutch Cancer Center · USSeattle Children's Hospital · USUniversity of Washington · USCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa · ZACatholic University of Korea · KRMolecular Oncology (United States) · US

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Infections in Hematopoietic Cell Transplant RecipientsK24HL093294 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BOECKH, MICHAEL J · 2009 to 2019
$1.5M
Viral and Host Biomarkers of Human Rhinovirus Disease Severity in TransplantationK23AI114844 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI WAGHMARE, ALPANA AMALKANT · 2015 to 2019
$897k
NCI NIH HHS P30 CA015704NHLBI NIH HHS K24 HL093294NIAID NIH HHS K23 AI114844
6 · The paper itself

Abstract

BACKGROUND.: The possible role of human coronavirus (HCoV) in lower respiratory tract disease (LRTD) in hematopoietic cell transplant (HCT) recipients and patients with hematologic malignancies (HM) has not been well studied. METHODS.: We conducted a retrospective review of HCT/HM patients with HCoV detected in bronchoalveolar lavage (BAL). HCoV strains were identified in BAL samples using strain-specific polymerase chain reaction. Mortality rates were compared among HCT recipients with LRTD caused by HCoV, respiratory syncytial virus (RSV), influenza virus, or parainfluenza virus (PIV) by multivariable Cox regression analysis. RESULTS.: We identified 35 patients (37 episodes) with HCoV LRTD. Among 23 available BAL samples, 48% were strain OC43, 22% were NL63, 17% were 229E, and 13% were HKU1. Overall, 21 patients (60%) required oxygen therapy at diagnosis and 19 (54%) died within 90 days of diagnosis. Respiratory copathogens were detected in 21 episodes (57%), including viruses (n = 12), fungi (n = 10), and bacteria (n = 8). Mortality rates were not different between patients with and without copathogens (P = .65). In multivariable models, mortality associated with HCoV LRTD was similar to that seen with RSV, influenza, and PIV LRTD in HCT recipients (adjusted hazard ratio, 1.34 [95% confidence interval, .66-2.71], P = .41 vs RSV, adjusted for cell source, cytopenia, copathogens, oxygen use, and steroid use). CONCLUSIONS.: HCoV LRTD in patients with HCT or HM is associated with high rates of oxygen use and mortality. Mortality associated with HCoV LRTD in HCT recipients appears to be similar to that seen with RSV, influenza virus, and PIV.

Indexed as

Hematopoietic Stem Cell TransplantationAdolescentAdultAgedBronchoalveolar LavageBronchoalveolar Lavage FluidChildCoronavirusCoronavirus InfectionsFemaleHematologic NeoplasmsHumansInfluenza, HumanMaleMiddle AgedPolymerase Chain Reactionbronchoalveolar lavagehematologic malignancy.hematopoietic cell transplanthuman coronaviruslower respiratory tract disease

Identifiers

PMID28329354
PMCPMC5434339
OpenAlexW2590459983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.